Laboratory Reference Ranges for Postmenopausal Women
In postmenopausal women not on hormone replacement therapy, estradiol should be <26 pmol/L (<7 pg/mL), FSH should be elevated above 20-30 IU/L (typically 40-138 IU/L), and LH should be elevated above 15-20 IU/L (typically 15-62 IU/L).
Diagnostic Framework
The Endocrine Society guideline 1 establishes that menopause diagnosis should primarily be clinical based on cessation of menses for 12 months. Laboratory testing is only suggested when establishing diagnosis is necessary in women who have undergone hysterectomy without bilateral oophorectomy or when menstrual history is inadequate. When laboratory confirmation is needed, the guideline recommends replicate measures of FSH and estradiol, with estradiol concentrations <20 pg/mL (approximately <73 pmol/L) supporting the diagnosis 1.
Specific Reference Ranges
Estradiol
- <26 pmol/L (<7 pg/mL) based on the most recent LC-MS/MS methodology 2
- This 2019 study used a highly accurate, CDC-traceable method and represents the gold standard for estradiol measurement
- Older studies report ranges of 25-49 pmol/L 3, 4, but the 2019 LC-MS/MS data should be prioritized as it uses superior methodology
FSH
- Typically 40-138 IU/L in established menopause
- Peak levels occur 2-3 years post-menopause at approximately 13-18 times premenopausal values 5
- Values ≥15-20 IU/L strongly suggest postmenopausal status, with 70-73% of women at these thresholds being postmenopausal 6
- Mean values around 55-73 IU/L are commonly observed 3, 4
LH
- Typically 15-62 IU/L in established menopause
- Peak levels occur 2-3 years post-menopause at approximately 3-3.4 times premenopausal values 5
- Mean values around 32-41 IU/L are commonly observed 3
- LH elevation is less dramatic than FSH elevation
Important Clinical Caveats
Temporal variation matters: Both gonadotropins reach peak levels 2-3 years after menopause, then gradually decline over subsequent decades to 40-50% of maximal levels 5. This means a woman 20 years postmenopausal may have lower FSH/LH than one who is 3 years postmenopausal.
Single measurements are unreliable: The guideline emphasizes replicate measures 1 because of significant day-to-day variation in reproductive hormones 7, 8. A single borderline value should not drive clinical decisions.
Correlation between hormones is weak: There is only minimal negative correlation between FSH and estradiol levels 4, so discordant results (e.g., elevated FSH with detectable estradiol) can occur and do not rule out menopause.
Smoking increases FSH: Current smoking is associated with elevated FSH levels 6, which can confound interpretation.
Prior oophorectomy affects levels: Women with unilateral oophorectomy may have higher FSH levels than those with both ovaries intact 6.
Practical Application
For clinical diagnosis of menopause in a woman with intact uterus and clear amenorrhea for 12 months, laboratory testing adds no value 1, 4. Reserve testing for ambiguous cases (hysterectomy, irregular bleeding patterns, premature menopause concerns) and always obtain replicate samples separated by at least 4-6 weeks to account for biological variation.